For all we know Mavis might be a great project. The fact is a company the size of Pioneer has too many projects to give it any attention or expenditure. Long term holders will be familiar with Dave's obsession with trendy commodities. Not because they have made us any money (The happy accident of Cs aside) but because they make good headlines and keep the cap raise train chugging.
That game is a bit long in the tooth for this company now imo. We do have some excellent prospects outside of Mavis that are likely to provide cash flow in the shorter term. Without those, there may be a bit of a cash squeeze in 12 months time. Long term survival and prosperity for this company will require that cash flow, and if Mavis cant be developed further, it should be divested.
- Forums
- ASX - By Stock
- ESS
- Ann: Spodumene results from Pioneer Dome North
Ann: Spodumene results from Pioneer Dome North, page-85
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ESS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online